HOME >> BIOLOGY >> NEWS
Fox Chase Cancer Center researcher publishes new findings on the developmental origin of liver and pancreas

PHILADELPHIA (February 27, 2001) -Research conducted at Fox Chase Cancer Center shows that cells which develop into the liver can also give rise to part of the pancreas, according to a new study published in the March issue of Development, Volume 128(6). The finding counters the assumption that during the early stages of mammalian development, the liver and pancreas cells develop from separate lineages.

Kenneth S. Zaret, Ph.D. and his research team had originally been studying the development of the liver in mouse embryos, and then discovered that the ventral part of the pancreas develops at the same time as the liver and from the same general domain of endoderm cells.

Different domains of the endoderm, an early embryonic tissue, normally differentiate into liver, lung, pancreas, thyroid, and intestine; yet how these diverse tissue domains are specified, and whether each tissue domain can give rise to other tissue derivatives, has been unclear. Differentiation is the process whereby embryonic cells become specialized in structure and function, and organize into the tissues and organs that make up the adult organism.

The goal of this research was to understand basic principles by which different cell types arise from a common cell population.

Dr. Zaret's group hypothesized that early embryonic cells that normally become the liver may also have the capacity to become the ventral part of the pancreas. They previously developed techniques for isolating cells from the ventral endoderm of a mouse embryo and for culturing the cells in the laboratory, allowing the researchers to closely follow the generation of the liver or pancreatic cell lineages.

Earlier, they used this culture method to show that fibroblast growth factor (FGF), a signal secreted from embryonic heart tissue, would cause nearby ventral endoderm cells to initiate liver development.

The embryonic liver normally originates next to the cardiac domain. In the present study, D
'"/>

Contact: Anjou K. Dargar
a_dargar@fccc.edu
215-728-7784
Fox Chase Cancer Center
26-Feb-2001


Page: 1 2

Related biology news :

1. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
2. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease
3. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
4. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
5. Fox Chase Cancer Center researchers identify significant smoking-induced genetic alteration
6. Fox Chase Cancer Center research reveals how COX-2 causes ovarian cancer
7. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
8. Fox Chase Cancer Center researcher develops new model for studying prions mad cow disease
9. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
10. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
11. Fox Chase Cancer Center researchers make significant discovery about function of p53

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2020)... ... August 21, 2020 , ... The August edition of ... is now available on the company’s global website. Crystallography Times—an electronic newsletter published ... current news and crystallographic research. , The latest issue of Crystallography Times ...
(Date:8/12/2020)... Mich. (PRWEB) , ... August 11, 2020 , ... ... R&D subsidiary based in Princeton, NJ, have entered into license agreements with Housey ... and development. Both Roche and J&J have annual Research and Development spending ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... company announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to provide ... clients to strengthen their laboratory supply chain for more than 10 years. Early ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... , ... August 11, 2020 ... ... biopharmaceutical cold chain validation engineering firm, is making available for free its ... need to incorporate concurrent transport simulation testing into today’s biologics licensing application ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now ... With 50 million stem cells total, patients may choose which extremities they would like ... arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as ... cover the history of eSource, the reasons it did not take off as quickly ... site source, the industry is moving towards capturing data electronically for clinical trials and ...
(Date:7/18/2020)... ... ... “We are thrilled to deliver this new technology to the industry” said ... on the market and we were pleased that the IFT jury recognized that.” reFRESH™ ... creating a natural way to extend the shelf life and improve the safety of ...
Breaking Biology Technology:
Cached News: